Prokidney (PROK) Total Current Liabilities (2021 - 2026)
Prokidney (PROK) reported Total Current Liabilities of $25.9 million for Q1 2026, down 20.96% year-over-year from $32.8 million in Q1 2025, and down 15.65% quarter-over-quarter from $30.7 million in Q4 2025.
Prokidney (PROK) Total Current Liabilities (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Total Current Liabilities data on file, last reported at $25.9 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $25.9 million, down 20.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.9 million (down 20.96% YoY), and the FY2025 annual result was $30.7 million, down 15.12% from the prior year.
- Total Current Liabilities retreated to $25.9 million in Q1 2026 per PROK's latest filing, from $30.7 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $36.2 million in Q4 2024 and troughed at $5.4 million in Q1 2022.
- A 5-year average of $21.4 million and a median of $24.5 million in 2023 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2026: Total Current Liabilities surged 17747.95% in 2022, then decreased 20.96% in 2026.
- A 5-year view of Total Current Liabilities shows it stood at $10.9 million in 2022, then soared by 130.28% to $25.0 million in 2023, then soared by 44.65% to $36.2 million in 2024, then dropped by 15.12% to $30.7 million in 2025, then dropped by 15.65% to $25.9 million in 2026.
- Business Quant data shows PROK's Total Current Liabilities at $25.9 million in Q1 2026, $30.7 million in Q4 2025, and $29.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | 25.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.93 Mn |
| Dec 31, 2025 | 30.74 Mn |
| Sep 30, 2025 | 29.06 Mn |
| Jun 30, 2025 | 28.26 Mn |
| Mar 31, 2025 | 32.81 Mn |
| Dec 31, 2024 | 36.22 Mn |
| Sep 30, 2024 | 25.18 Mn |
| Jun 30, 2024 | 20.59 Mn |
| Mar 31, 2024 | 19.30 Mn |
| Dec 31, 2023 | 25.04 Mn |
| Sep 30, 2023 | 20.99 Mn |
| Jun 30, 2023 | 24.50 Mn |
| Mar 31, 2023 | 11.28 Mn |
| Dec 31, 2022 | 10.87 Mn |
| Sep 30, 2022 | 9.84 Mn |
| Jun 30, 2022 | 7.93 Mn |
| Mar 31, 2022 | 5.41 Mn |
| Dec 31, 2021 | 12.31 Mn |
| Sep 30, 2021 | 55,138.00 |
| Jun 30, 2021 | 603,129.00 |